Skip to main content

Table 5 Average annual total societal costs and 95% credible intervals (CIs) per vaccination strategy in millions of USD

From: Seasonal influenza vaccination in Kenya: an economic evaluation using dynamic transmission modelling

  Strategy            
  I     II     III    
Year A B C D A B C D A B C D
2010 10.47 (4.99–22.4) 12.3 (5.58–26.8) 13.22 (7.12–26.02) 15.52 (9.08–28.28) 14.53 (9.47–23.82) 18.44 (10.87–33.1) 20.02 (13.42–31.01) 24.77 (17.12–36.28) 28.65 (21.06–38.28) 35.14 (24.28–51.56) 39.53 (29.07–52.79) 50.31 (37.05–66.96)
2010–11 25.7 (9.89–58.27) 25.32 (9.79–57.84) 27.2 (11.9–58.74) 29.96 (14.23–62.08) 30.6 (15.28–61.51) 29.75 (15.14–59.51) 33.38 (18.94–61.44) 39.04 (23.2–68.8) 44.11 (28.7–70.93) 44.27 (28.78–70.65) 50.86 (35.6–72.91) 63.32 (44.63–89.53)
2011–12 27.85 (10.44–63.18) 26.96 (10.19–61.17) 29.64 (12.57–64.32) 32.28 (14.84–67.11) 34.33 (16.4–69.85) 32.08 (15.76–64.48) 37.58 (20.31–70.94) 42.95 (24.54–77.14) 51.94 (31.52–88.39) 45.96 (29.32–74.06) 58.5 (38.79–89.58) 70.68 (48.1–104.96)
2012–13 10.96 (5.05–25.92) 12.94 (5.51–30.84) 13.93 (7.26–29.65) 16.59 (9.34–32.58) 15.3 (9.94–25.72) 19.59 (11.17–37.81) 21.21 (14.09–34.17) 26.68 (18.09–41.05) 30.86 (22.82–40.92) 37.68 (25.53–57.45) 42.45 (31.39–56.29) 54.35 (40.13–72.27)
2013–14 17.72 (7.9–37.94) 15.64 (7.3–32.6) 18.74 (9.82–36.49) 21.31 (12.07–39.21) 24.55 (14–44.98) 19.79 (12.29–33.19) 26.16 (17.02–41.7) 31.41 (21.16–47.5) 43.13 (29.18–64.84) 33.28 (24.47–44.45) 46.15 (33.91–61.7) 58.33 (43.01–77.66)
2015–16 48.3 (16.51–113.91) 48.47 (16.56–114.58) 50.31 (18.88–114.99) 53.37 (21.44–118.68) 52.91 (22.38–115.21) 53.61 (22.69–116.66) 56.94 (27.06–117.17) 63.21 (32.38–124.8) 64.18 (37.24–116.25) 68.06 (38.78–124.43) 73.27 (46.12–121.35) 87.82 (57.09–139.53)
2017–18 28.72 (10.86–68.26) 27.17 (10.44–64.33) 29.46 (12.91–65.93) 32.54 (15.56–69.14) 33.57 (17–68.92) 31.08 (16.29–61.99) 34.85 (20.51–63.09) 41.42 (25.5–71.71) 48.72 (32.39–75.87) 48.1 (31.97–74.92) 52.83 (38.48–70.92) 67.61 (49.24–90.92)
  1. Strategies are vaccinating children 6–23 months (strategy I), 2–5 years (strategy II) and 6–14 years (strategy III) with either the Southern Hemisphere influenza vaccine (Strategy A) or Northern Hemisphere vaccine (Strategy B) or both (Strategy C: twice yearly 3-month vaccination periods, or Strategy D: year-round vaccination)